{
    "Title": "Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey",
    "URL": "https://doi.org/10.1371/journal.pntd.0004352",
    "Published": "January 15, 2016",
    "Subject_Areas": [
        "Trachoma",
        "Antibodies",
        "Chlamydia trachomatis",
        "Age groups",
        "Antibody response",
        "Respiratory infections",
        "Enzyme-linked immunoassays",
        "Chlamydia infection"
    ],
    "Authors": {
        "Sheila K. West": [
            "Dana Center for Preventive Ophthalmology, Johns Hopkins University, Baltimore, Maryland, United States of America"
        ],
        "Beatriz Munoz": [
            "Dana Center for Preventive Ophthalmology, Johns Hopkins University, Baltimore, Maryland, United States of America"
        ],
        "Jerusha Weaver": [
            "Dana Center for Preventive Ophthalmology, Johns Hopkins University, Baltimore, Maryland, United States of America"
        ],
        "Zakayo Mrango": [
            "National Institute for Medical Research, Kilosa, Tanzania"
        ],
        "Laura Dize": [
            "Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, United States of America"
        ],
        "Charlotte Gaydos": [
            "Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, United States of America"
        ],
        "Thomas C. Quinn": [
            "Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, United States of America",
            "Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America"
        ],
        "Diana L. Martin": [
            "Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America"
        ]
    }
}